These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9666517)

  • 1. Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer.
    Ito K; Fujimori M; Nakata S; Hama Y; Shingu K; Kobayashi S; Tsuchiya S; Kohno K; Kuwano M; Amano J
    Oncol Res; 1998; 10(2):99-109. PubMed ID: 9666517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers.
    Kim WJ; Kakehi Y; Wu WJ; Fukumoto M; Yoshida O
    Br J Urol; 1996 Sep; 78(3):361-8. PubMed ID: 8881943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
    Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
    Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
    Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
    J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
    Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
    J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
    Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
    Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
    Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
    J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of multidrug resistance associated protein(MRP) gene expression in acute leukemia].
    Wang F; Dong Z; Luo J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):63-6. PubMed ID: 10921103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
    Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.
    Vanhoefer U; Voigt W; Hilger RA; Yin MB; Harstrick A; Seeber S; Rustum YM
    Oncol Res; 1997; 9(9):485-94. PubMed ID: 9495454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
    Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
    Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
    Beck J; Niethammer D; Gekeler V
    Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
    Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
    N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
    Zhao M; Yu S; Zhang M
    Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.